Voyager Acquisition Corp Class A Ordinary Shares

€9.138
EUR
Last updated on --.
24h volume13.58K
24h highest10.2610 EUR
24h lowest9.0491 EUR
24h Price movement-0.79%

VACH recent prices

24 Hours
-0.79%-€0.073109
30 days
-9.58%-€1.058
60 days
-5.22%-€0.55046
90 days
+8.61%+€0.79129

Key data

Previous close9.2117 EUR
Market cap299.48M EUR
Volume13.58K
P/E ratio34.910000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.27523 EUR
Net income (FY)7.73M EUR
Revenue (FY)--
Last report dateMar 10, 2026

About Voyager Acquisition Corp Class A Ordinary Shares

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersHOUSTON
Employees (FY)3.00
Net income per employee (FY)2.58M EUR
Listed onNasdaq
Official website

VACH conversion tables

VACHVACH
EUREUR
0.5 VACH4.569 EUR
1 VACH9.138 EUR
5 VACH45.69 EUR
10 VACH91.38 EUR
EUREUR
VACHVACH
0.5 EUR0.054713 VACH
1 EUR0.10943 VACH
5 EUR0.54713 VACH
10 EUR1.094 VACH

FAQ

VACH is trading at €9.138, -0.79% over the last 24 hours. Track live moves on the price chart at the top of this page.
The VACH stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. VACH is currently trading at €9.138, -0.79% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on VACH price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. VACH's P/E ratio is currently 34.910000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from VACH; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against VACH's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Voyager Acquisition Corp Class A Ordinary Shares's market cap is currently 299.48M EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume13.58K
24h highest10.2610 EUR
24h lowest9.0491 EUR
24h Price movement-0.79%
VACHVACH
EUREUR
Start trade with VACH Perpetual